Low dose corticosteroids in COVID-19 with refractory shock:We are not sure?  

作　　者：Amr Salah Omar 

机构地区：[1]Department of Cardiothoracic Surgery/Cardiac Anaesthesia and ICU,Heart Hospital,Hamad Medical Corporation,Doha 3050,Qatar [2]Department of Critical Care Medicine,Beni Suef University,Beni Suef 71515,Egypt [3]Department of Medicine,Weill Cornell Medical College in Qatar,Doha 3050,Qatar

出　　处：《World Journal of Anesthesiology》2020年第1期1-2,共2页世界麻醉学杂志

摘　　要：Low dose corticosteroids to adult patients with coronavirus disease 2019(COVID-19)and refractory shock was given some evidence,the evidence was of low quality given particularly for shock-reversal.Evidence.However bacterial sepsis may not provide a similar evidence like in a viral related one.We think that suggesting steroids for COVID-19 may not be adequate in the current time and future data analysis should be directed to find possible evidence in a matched population.

关 键 词：CORTICOSTEROIDS SEPSIS Shock COVID-19 REFRACTORY OUTCOME 

分 类 号：R57[医药卫生—消化系统]